Clinical Trials on Herpesvirus 2, Human

Total 18655 results

University of Washington
Hoffmann-La Roche

Completed

Suppression of Oral HHV8 Shedding With Valganciclovir

Human Herpesvirus 8

United States
National Institute of Allergy and Infectious Diseases...
Comprehensive International Program of Research on AIDS

Completed

Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)

HIV Infections | Herpesvirus 2, Human

Peru
Kirby Institute
National Institute of Allergy and Infectious Diseases (NIAID); ViiV Healthcare and other collaborators

Withdrawn

Inflammation and Co-Infections in D²EFT (i2-D²EFT)

Cytomegalovirus Infections | Human Papilloma Virus | HIV-infection/Aids | Human Herpesvirus 4 Infections | Human Herpesvirus 8 Infection
National Center for AIDS/STD Control and Prevention...
Sichuan Center for Disease Control and Prevention; Guizhou Center for Disease... and other collaborators

Unknown

(Men Who Have Sex With Men) MSM Community Intervention Trial

HIV | Syphilis | Herpesvirus 2, Human

China
National Institute of Allergy and Infectious Diseases...
Fogarty International Center of the National Institute of Health

Completed

Male Circumcision for HIV Prevention in Rakai, Uganda

HIV Infections | Syphilis | Genital Diseases, Male | Herpesvirus 2, Human

Uganda
Rambam Health Care Campus

Unknown

The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) in a Saliva of the Patient With Periodantitis

Epstein-Barr Virus Infections | Cytomegalovirus | Herpesvirus Infection

Israel
Emory University

Completed

Herpesvirus in Idiopathic Pulmonary Fibrosis

Lung Diseases | Herpesvirus Infections

United States
National Cancer Institute (NCI)
National Taiwan University Hospital; Mackay Memorial Hospital; Cathay General... and other collaborators

Terminated

Environmental and Genetic Determinants of NPC

Nasopharyngeal Neoplasms | Herpesvirus 4, Human

Taiwan
Liverpool School of Tropical Medicine
Centers for Disease Control and Prevention; Kenya Medical Research Institute; Safe Water and AIDS Project (SWAP), Kenya

Completed

Cups or Cash for Girls Trial to Reduce Sexual and Reproductive Harm and School Dropout (CCg)

HIV Infections | Quality of Life | Adolescent Behavior | Reproductive Health | Herpesvirus Infection | Woman Abuse

Kenya
National Cancer Institute (NCI)

Completed

Family Study of Head and Neck Cancers in Taiwan

Nasopharyngeal Neoplasms | Herpesvirus 4, Human

China
Gruppo Italiano Trapianto di Midollo Osseo
Azienda Policlinico Umberto I

Completed

Prospective Survey of CMV, Herpesviruses Infections and Diseases in Allo-HSCT (CYTOALLOSURVEY)

Hematologic Diseases | Stem Cell Transplant Complications | Cytomegalovirus Viremia | Herpesvirus Infection

Italy
University of KwaZulu
AIDS Malignancy Consortium; National Research Foundation, Singapore; AIDS Care... and other collaborators

Completed

HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT (KAART)

HIV | Kaposi's Sarcoma | AIDS | Human Herpesvirus 8

South Africa
G.V. (Sonny) Montgomery VA Medical Center

Unknown

Herpes Simplex Type 2 Co-infection in Veterans With Chronic Hepatitis C

Hepatitis C Virus Infection | Infection | Herpesvirus 2, Human

United States
Tongji Hospital
Wuhan University; Wuhan Central Hospital; Wuhan Fourth Hospital

Recruiting

The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus (SDCMK)

Dilated Cardiomyopathy | Kaposi's Sarcoma-Associated Herpesvirus Infection

China
University of California, Los Angeles
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Natural History of HPV From Infection to Neoplasia in Adolescents and Young Women

Human Papillomavirus | CIN 3 | CIN 2

United States
National Cancer Institute (NCI)

Completed

Epidemiology of Burkitt Lymphoma in East Africa Children or Minors (EMBLEM)

Lymphoma, Non-Hodgkin | Malaria | Herpesvirus 4, Human

Tanzania, Uganda
Hunan Cancer Hospital

Recruiting

Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Herpesvirus 4, Human

China
St. Jude Children's Research Hospital

Active, not recruiting

T-cell Responses to Concurrent HIV and Herpesvirus Infections

HIV Infections | HIV

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety of a Live Attenuated Human Parainfluenza Virus Type 2 (HPIV2) Vaccine for Adults, Children, and Infants

Human Parainfluenza Virus 2

United States
University Hospital, Gentofte, Copenhagen
Danish Heart Foundation

Completed

Vasodilatory and Metabolic Effects of Glucagon-like Peptide-1 in Periphery Circulation in Patients With and Without Type 2 Diabetes Mellitus

Type 2 Diabetes | Blood Flow | Human Physiology | Glucagon-like Peptide-1 | Blod Pressure

Denmark
Alios Biopharma Inc.

Completed

A Drug-Drug Interaction Study to Evaluate the Effect of AL-794 on the Pharmacokinetics of Oseltamivir and JNJ-63623872

Influenza in Humans

United Kingdom
Biocad

Completed

A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer Patients

Human Epithelial Receptor (HER)-2 Positive Breast Cancer

Ukraine, Russian Federation, Belarus, India
Guangdong Academy of Medical Sciences
Guangzhou First People's Hospital; Guangzhou General Hospital of Guangzhou... and other collaborators

Unknown

Compare the Outcomes of XT and XEC Adjuvant Chemotherapy in HER2-negative Luminal B Breast Cancer Patients

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

China
Istituto Scientifico Romagnolo per lo Studio e...

Completed

Myocet + Cyclophosphamide + Metformin Vs Myocet + Cyclophosphamide in 1st Line Treatment of HER2 Neg. Metastatic Breast Cancer Patients (MYME)

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Italy
Qingdao Central Hospital

Completed

Radiotherapy Alternates Human Epidermal Growth Factor 2 (Her2) Expression in Human Breast Cancer

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

China
Borstkanker Onderzoek Groep
Roche Pharma AG; Teva Pharma

Completed

8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast Cancer (Stop&Go)

Metastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Netherlands
Gustave Roussy, Cancer Campus, Grand Paris
European Commission

Completed

Identification of Early Markers of Response and Resistance to Trastuzumab (HERBIN)

Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer

France
Consorzio Oncotech
Clinical Research Technology S.r.l.

Unknown

Safety and Efficacy Study of Eribulin in Combination With Bevacizumab for Second-line Treatment HER2- MBC Patients (GIM11-BERGI)

Metastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Italy
ModernaTX, Inc.

Active, not recruiting

A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults

Influenza | SARS-CoV-2

United States
ModernaTX, Inc.

Active, not recruiting

A Study of mRNA-1083 (SARS-Cov-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age

Influenza | SARS-CoV-2

United States
University of Chicago

Not yet recruiting

Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery

Breast Cancer | HER2-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

United States
ModernaTX, Inc.

Completed

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old

Influenza | SARS-CoV-2

United States
Karolinska University Hospital
Karolinska Institutet

Recruiting

Study of Human Adipose Tissue (LOSHAT) (LOSHAT)

Obesity | Type 2 Diabetes Mellitus | Weight Loss | Weight Gain | Weight Change, Body | Adipose Tissue | Human | Lipolysis

Sweden
Hipra Scientific, S.L.U

Completed

A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19

Influenza, Human | SARS CoV 2 Infection

Spain
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of Oral Navelbine in Female Patients With HER2-Negative Metastatic Breast Cancer

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Astellas Pharma Global Development, Inc.
Medivation LLC, a wholly owned subsidiary of Pfizer Inc.

Completed

A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer

Advanced Breast Cancer | HER2 Amplified | Human Epidermal Growth Factor Receptor 2 (HER2)

United States, Belgium, Canada, Italy, Spain, United Kingdom
Dana-Farber Cancer Institute
Pfizer

Completed

Palbociclib With Everolimus + Exemestane In BC

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor (HR)-Positive Breast Cancer

United States
AdventHealth Translational Research Institute

Recruiting

Development and Validation of Multi-nuclear Magnetic Resonance Imaging and Spectroscopy for Whole Body Human Applications (MRS VALIDATION)

Human Body Composition | Human Body Function

United States
MedSIR
Pfizer

Completed

PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA) (PALMIRA)

Breast Cancer | Advanced Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Spain, Germany, France, United Kingdom, Italy, Slovenia
National Institute of Allergy and Infectious Diseases...

Recruiting

Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons

Epstein-Barr Virus Infection | Infectious Mononucleosis | Herpesvirus

United States
ModernaTX, Inc.

Completed

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old

Influenza | SARS-CoV-2 | RSV

United Kingdom, Australia, United States
Georgetown University
Pfizer

Active, not recruiting

WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor

Metastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor Positive Breast Cancer

United States
Dana-Farber Cancer Institute
Eisai Inc.

Active, not recruiting

A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer

Inflammatory Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

United States
Helwan University

Not yet recruiting

Palbociclib in Metastatic Breast Cancer: Gene Polymorphism-based Study in Egyptian Patients. (Palbociclib)

Metastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone-receptor-positive Breast Cancer
iOMEDICO AG
Pfizer

Completed

Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or Fulvestrant (INGE-B)

Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Germany
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute

Terminated

A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older

Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Node-negative Breast Cancer

United States
Services Institute of Medical Sciences, Pakistan
Getz Pharma

Completed

The Role Of Nitazoxanide, Interferon Alfa And Ribavirin In Treatment Of Hepatitis C Infected Type 2 Diabetic Patients (HEP-C-FM)

Hepatitis C, Chronic | DIABETES MELLITUS Type 2

Pakistan
Reshma L. Mahtani, D.O.
Gilead Sciences

Not yet recruiting

Sequencing Antibody Drug Conjugates in ER+/HER2 LOW MBC (SERIES)

Breast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Hormone-receptor-positive Breast Cancer | Human Epidermal Growth Factor 2 Low Breast Cancer

United States
University of Versailles
Assistance Publique - Hôpitaux de Paris

Terminated

Low Doses Corticosteroids as Adjuvant Therapy for the Treatment of Severe H1N1 Flu (CORTIFLU)

Pneumonia, Viral | Influenza in Humans

France
Consorzio Oncotech
Clinical Research Technology S.r.l.

Unknown

Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer (FEVEX)

Breast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Locally Advanced Malignant Neoplasm

Italy

Clinical Trials on Herpesvirus 2, Human

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations